Fengler Justin: insider trades.
Fengler Justin reported 12 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Fengler Justin
Companies
| Company | Relationship | Transactions |
|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | Officer · See Remarks | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | GoodRx Holdings, Inc. | M | 2,335 | — | 53,111 | Form 4 |
| 2026-09-15 | GoodRx Holdings, Inc. | F | 330 | $3.56 | 52,509 | Form 4 |
| 2026-09-15 | GoodRx Holdings, Inc. | M | 752 | — | 52,839 | Form 4 |
| 2026-09-15 | GoodRx Holdings, Inc. | F | 1,024 | $3.56 | 52,087 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 6,423 | — | 35,648 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 2,817 | $3.73 | 32,831 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 6,392 | — | 39,223 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 2,803 | $3.73 | 36,420 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 11,212 | $3.73 | 50,776 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 4,575 | $3.73 | 29,225 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 10,149 | — | 33,800 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 25,568 | — | 61,988 | Form 4 |
Questions
What stock did Fengler Justin buy or sell?
Fengler Justin reported 12 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Fengler Justin the same person as other filers with this name?
This page covers SEC CIK 2149552 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/fengler-justin-2149552.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.